Thermoregulation Part 1
Overview of Thermoregulation and Burns
Course: Medical-Surgical Nursing II
Focus: Understanding burn injuries and their management
Learning Objectives:
Classification of burn injuries
Considerations for pediatric and geriatric patients
Local and systemic effects of burns
Fluid and electrolyte alterations in burn management phases
Nursing management for clients with burns
Emergency management comparisons: heat stroke, frostbite, hypothermia
Prioritization of interventions for hyperthermic toxidromes
Note: Contains graphic images, viewer discretion advised
Classification of Burns
1st Degree (Superficial Burns):
Affects: Only the epidermis (e.g., sunburn)
Characteristics: Reddened skin that blanches with pressure, minimal edema; may develop blisters and peeling after a few days.
Healing: Typically resolves within a few days with minimal intervention and minimal risk of scarring.
2nd Degree (Partial Thickness):
Superficial Partial Thickness:
Affects: Epidermis and the upper part of the dermis.
Symptoms: Increased pain, blisters, red/edematous base.
Healing: 2-3 weeks with the potential for scarring, requiring specialized wound care to prevent infection.
Deep Partial Thickness:
Affects: Deep layers of the dermis.
Symptoms: Weeping surface, significant pain, prolonged healing, and may require surgical intervention (such as grafting) for optimal recovery.
3rd Degree (Full Thickness):
Affects: Destroys epidermis, dermis, and may impact subcutaneous tissue, muscle, and bone.
Characteristics: Skin appears dry, leathery, and charred.
Symptoms: High risk of shock, myoglobinuria (presence of myoglobin in urine), and visible coagulated vessels; often requires pain management and may need extensive surgery for healing.
Recovery: Prolonged healing process; often requires grafting or amputation of affected areas.
4th Degree Burns:
Affects: Extends beyond the skin and subcutaneous tissue to muscle and bone.
Symptoms: Similar to third degree burns, with even greater risk of complications including infection, muscle damage, and amputation, necessitating advanced medical intervention.
Pediatric and Geriatric Considerations
Pediatric Patients:
Challenges: Faster fluid loss, making them more susceptible to hypovolemic shock and abuse;
Metabolic Needs: Higher energy requirements and less mature immune systems increase vulnerability to infection and complications.
Healing: Generally shows resilience in healing due to rapid skin turnover, however, careful monitoring for growth and development changes is essential.
Geriatric Patients:
Skin Characteristics: Thinner and less elastic skin; slower healing processes.
Comorbidities: Higher likelihood of existing comorbidities like heart disease and diabetes can complicate recovery and management.
Physical Limitations: Reduced coordination, strength, and often vision impairments increase the likelihood of both thermal and chemical burns.
Types of Burns
Thermal Burns: Caused by contact with heat sources (e.g., flames, hot liquids, steam).
Radiation Burns: Result from UV exposure (sunburn) or therapeutic radiation treatment for cancer.
Chemical Burns: Occur from contact with strong acids, alkalis, or solvents; immediate identification and decontamination are vital.
Electrical Burns: Caused by electrical current passing through the body (alternating current (AC) or direct current (DC)); can lead to significant internal tissue damage despite minimal external injury.
Friction Burns: Result from skin rubbing against hard surfaces; usually superficial but can cause significant pain and risk of infection.
Burn Care and Management Phases
Emergent Phase:
Focus: Initial assessment of airway, breathing, circulation, and prevention of shock; stabilization of vital signs is critical.
Fluid Resuscitation: Administer intravenous fluids rapidly to prevent shock; calculate fluid requirements using the Parkland formula.
Acute Phase:
Duration: From diuresis to complete wound closure.
Management Strategies: Emphasize proper wound care to prevent infection, nutritional support to meet increased metabolic demands, and psychological support as needed.
Rehabilitation Phase:
Goals: Restore optimal physical and psychosocial functioning; minimize the impact of scarring and contractures through therapy and surgical interventions.
Monitoring: Be alert to psychological impacts of burns, requiring support from mental health services.
Fluid and Electrolyte Management
Parkland Formula: 4 mL/kg/% Total Body Surface Area (TBSA) burned for fluid resuscitation.
Administer half of the calculated volume in the first 8 hours; remaining volume is given over the next 16 hours.
Preferred Fluid: Lactated Ringer's solution is recommended for initial resuscitation.
Monitoring: Regularly assess for complications such as respiratory failure, acute kidney injury, electrolyte imbalances, and contractures for effective management.
Emergency Management of Conditions Related to Burns
Heat Stroke
Description: A serious condition where the body fails to regulate its temperature, leading to potentially fatal outcomes.
Symptoms: Extremely high body temperature (106°F or higher), dry skin, rapid pulse, confusion, and the potential for loss of consciousness.
Treatment: Immediate cooling of the body through various methods, hydration, and electrolyte support are vital to stabilize the patient.
Frostbite
Description: Freezing of body tissues, most commonly affecting the extremities.
Symptoms: Discolored skin, lack of feeling or sensation, and potential blister formation on thawing.
Treatment: Gentle rewarming in warm water (98.6°F - 104°F) while avoiding excessive rubbing or pressure on affected areas.
Hypothermia
Description: A life-threatening condition occurring when the body temperature drops below 95°F.
Symptoms: Shivering, confusion, loss of coordination, and potential loss of consciousness.
Treatment: Gradual rewarming, prioritizing core body temperature while closely monitoring vital signs.
Nursing Management and Considerations
Assessment: Continuous assessment of airway, breathing, circulation, and fluid balance; observe for early signs of development of complications.
Pain Management: Regular management of pain is crucial, especially during wound care procedures which can provoke significant discomfort.
Family Involvement: Member of family should be educated and encouraged to participate in care, fostering communication and emotional support through the healing process.
Psychological Support: Aimed at minimizing the psychological impact of burns and supporting overall recovery.
Hyperthermic Toxidromes
General Treatment Strategies:
Identify the causative factor and provide airway breathing and circulatory-focused care.
Control body temperature and restore fluid and electrolyte balance; monitor the patient for complications like seizures and arrhythmias.
Types of Syndromes:
Malignant Hyperthermia: A genetic condition that can occur during anesthetic procedures resulting in muscle rigidity and dangerously high body temperatures; immediate intervention with dantrolene is crucial.
Serotonin Syndrome: Caused by excessive serotonergic activity, presenting with altered mental status, autonomic instability, and increased neuromuscular activity; requires discontinuation of serotonergic drugs and symptomatic management.
Additional Considerations
Coordination with Specialists: For severe burns, there is a high importance to coordinate care with specialized burn centers.
Community Resources: Awareness of available community resources for ongoing rehabilitation and support is crucial for long-term recovery.
Monitoring Long-term Effects: Continuous monitoring of the patient post-injury is necessary to address long-term effects and wellness during recovery.
Stages of Frostbite (Detailed with Symptoms)
Frostnip:
Description: The mildest form of frostbite, affecting only the surface of the skin.
Symptoms:
Skin appears red, cold to the touch.
Limited sensation changes, such as tingling or numbness.
No permanent tissue damage occurs.
Treatment:
Effective rewarming of the affected area usually restores normal function.
Superficial Frostbite:
Description: Affects the skin and the upper layers of tissue underneath.
Symptoms:
Skin may look pale or waxy, and feels cold and hard.
Redness can occur upon rewarming.
Blisters may form within 24 hours; affected area may be painful or tender.
Sensation is decreased, and numbness may be present.
Treatment:
Rewarming in warm (not hot) water and keeping the area protected.
Deep Frostbite:
Description: Extends deeper into the tissue, affecting the skin, muscles, tendons, and potentially nerves.
Symptoms:
The affected area feels hard and may have a waxy appearance.
There is complete loss of sensation in the affected area, including tingling or pain.
Blisters may form, and skin may appear purple or blue when rewarming, indicating blood flow issues.
Risk of infection and complications significantly increases.
Treatment:
Requires medical evaluation; treatment may include gradual rewarming, monitoring for complications, and wound management if necessary.
### Care for Frostbite 1. **Frostnip**: - **Overview**: The most mild form of frostbite, impacting only the outer skin layer. - **Indicators**: - Skin presents as red and feels cold. - Minor changes in sensation like tingling or numbness. - No lasting tissue damage is evident. - **Care**: - Promptly rewarming the area often restores normal function. 2. **Superficial Frostbite**: - **Overview**: Involves the skin and the upper layers of tissue. - **Indicators**: - Skin may take on a pale or waxy look and feels cold and firm. - Redness may become apparent upon rewarming. - Blisters can develop within 24 hours, and the affected area may exhibit pain or tenderness. - Decreased sensation and possible numbness can occur. - **Care**: - Immerse in warm (not hot) water and protect the area from further injury. 3. **Deep Frostbite**: - **Overview**: Penetrates deeper into tissues involving skin, muscles, tendons, and possible nerve damage. - **Indicators**: - The affected area feels very hard and might have a waxy texture. - Complete loss of feeling occurs, which can include tingling or pain. - Blisters may form, and the skin can turn purple or blue during rewarming, which signals blood circulation problems. - Elevated risk of infection and other complications exists. - **Care**: - Requires immediate medical assessment; treatment could involve gradual rewarming, oversight for complications, and necessary wound management.
Nursing Management for Hypothermia Treatment
Assessment: Conduct thorough evaluations, focusing on airway, breathing, circulation, and temperature. Look for signs of hypothermia, including shivering, confusion, and impaired motor functions.
Immediate Interventions:
Gently remove wet clothing and provide warm, dry blankets to prevent further heat loss.
Initiate gradual rewarming methods, such as placing the patient near a source of warmth or using warm, dry compresses on the neck, chest, and groin areas.
Monitor vital signs closely during rewarming; be vigilant for potential complications such as cardiac arrhythmias or respiratory issues.
Fluid Management: Administer warmed intravenous fluids cautiously to maintain hydration and electrolyte balance, keeping in mind the risk of rapid temperature changes and associated complications.
Psychological Support: Provide reassurance to the patient as they may be disoriented or fearful due to their condition, fostering a calm environment during treatment.
Education: Inform the patient and family about hypothermia and its prevention to enhance understanding and reduce risk in the future. ## Types of Hyperthermic Toxidromes -
Types of Hyperthermic Toxidromes
Malignant Hyperthermia:
A hereditary condition that may develop during anesthesia, resulting in severe muscle rigidity and dangerously high body temperatures. Immediate intervention with dantrolene is crucial for management.
Serotonin Syndrome:
Arises from excessive activity of serotonin in the brain, presenting with symptoms such as altered mental state and increased neuromuscular activity. Treatment involves stopping serotonergic drugs and providing appropriate supportive care.
Neuroleptic Malignant Syndrome:
A critical response to antipsychotic medications marked by elevated body temperature, muscle rigidness, and altered consciousness. The management strategy includes discontinuing the responsible medication and offering supportive care.
Anticholinergic Toxicity:
Occurs due to an overdose of anticholinergic substances, leading to an increase in body temperature, confusion, and autonomic instability. Treatment often requires the administration of physostigmine to counteract symptoms.
Stimulant-Induced Hyperthermia:
Results from the use of stimulants, such as amphetamines or cocaine, which elevate metabolic activity and body temperature. Care involves supportive measures and cooling practices.
Sympathomimetic Toxicity:
Caused by substances that mimic the sympathetic nervous system, leading to increased heart rate, hypertension, hyperthermia, and often agitation. Management typically includes benzodiazepines for sedation and intravenous fluids.
Anticholinergic Toxidrome:
Similar to anticholinergic toxicity but focuses on the syndrome presenting with dry skin, flushed face, increased heart rate, and hyperthermia due to system-wide anticholinergic effects. This is treated with supportive care and sometimes with antidotes like physostigmine, depending on severity.
Types of Hyperthermic Toxidromes
Malignant Hyperthermia:
Mechanism: A genetic defect in the ryanodine receptor leads to uncontrolled calcium release from the sarcoplasmic reticulum of skeletal muscles during anesthesia.
Causes: Often triggered by certain anesthetic agents like halothane or succinylcholine in genetically predisposed individuals.
Time of Exposure: Symptoms can occur within minutes of exposure to anesthetic agents.
Temperature: Body temperature can rise to 106°F or higher.
Muscle Tone: Severe muscle rigidity occurs.
Reflexes: Hyperreflexia may be present.
Skin: Warm to hot skin, possibly mottled.
Urine: Dark, tea-colored urine due to myoglobinuria.
Bowel Sounds: Normal or decreased as a result of muscle rigidity and autonomic dysregulation.
Diagnostic: Increased creatine kinase levels and metabolic acidosis are indicative.
Treatment: Immediate administration of dantrolene, supportive care, and cooling measures are essential.
Serotonin Syndrome:
Mechanism: Excessive serotonergic activity in the central nervous system.
Causes: Often results from the interaction or overdose of serotonergic drugs (e.g., SSRIs, SNRIs, and certain recreational drugs).
Time of Exposure: Can develop rapidly, sometimes within hours of drug use or adjustment.
Temperature: Body temperature can exceed 104°F.
Muscle Tone: Increased muscle tone and rigidity may be noted.
Reflexes: Hyperreflexive with possible clonus.
Skin: Flushed, diaphoretic skin.
Urine: Mydriasis (dilated pupils) may yield normal urine output.
Bowel Sounds: Hyperactive.
Skin Tones: May appear reddened or mottled due to altered thermoregulation.
Diagnostic: Clinical diagnosis based on symptoms and medication history.
Treatment: Discontinuation of serotonergic agents, supportive care, and possible administration of cyproheptadine for severe cases.
Neuroleptic Malignant Syndrome:
Mechanism: Antipsychotic-induced dopamine receptor blockade causing severe muscle rigidity and metabolic dysregulation.
Causes: Associated with the use of antipsychotic medications, particularly first-generation (typical) antipsychotics.
Time of Exposure: Symptoms can develop within the first two weeks after initiation or dose increase.
Temperature: Can rise to 104°F or higher.
Muscle Tone: Extreme rigidity is prevalent.
Reflexes: Diminished or absent reflexes may occur.
Skin: Hot, dry skin due to autonomic dysregulation.
Urine: Rarely shows specific changes, but dehydration may lead to concentrated urine.
Bowel Sounds: Decreased bowel activity due to muscle rigidity.
Diagnostic: Elevated creatine kinase and leukocytosis; clinical assessment is key.
Treatment: Discontinue neuroleptics, provide supportive care, and administer dantrolene or bromocriptine to alleviate symptoms.
Anticholinergic Toxicity:
Mechanism: Blockade of acetylcholine receptors in the central and peripheral nervous systems.
Causes: Overdose of anticholinergic medications (e.g., atropine, scopolamine) or plants (e.g., belladonna).
Time of Exposure: Symptoms can emerge within one hour of exposure.
Temperature: Hyperthermia can exceed 103°F; difficulty regulating temperature.
Muscle Tone: Normal muscle tone with possible muscle weakness.
Reflexes: Diminished reflexes.
Skin: Dry, flushed skin; may present with rash.
Urine: Decreased urination; may become concentrated.
Bowel Sounds: Decreased bowel sounds due to reduced GI motility.
Skin Tones: Red and dry skin may be observable.
Diagnostic: Based on symptomatology and drug history; possible use of serum anticholinergic activity tests.
Treatment: Administration of physostigmine for severe cases, along with supportive care.
Stimulant-Induced Hyperthermia:
Mechanism: Increased catecholamine release causing elevated metabolic rates.
Causes: Excessive use of stimulants like cocaine, methamphetamine, or MDMA.
Time of Exposure: Symptoms usually present within minutes to hours of use.
Temperature: Body temperature can spike to 104°F or higher.
Muscle Tone: Increased muscle tone and potential hyperactivity.
Reflexes: Hyperreflexive.
Skin: Flushed and sweaty; possible pallor.
Urine: Mydriasis (dilated pupils) with possible changes in urine color due to dehydration.
Bowel Sounds: Hyperactive or normal.
Diagnostic: Clinical evaluation and toxicology screen; assess for other complications.
Treatment: Supportive care involving cooling measures, intravenous fluids, and monitoring vital signs closely.
Sympathomimetic Toxicity:
Mechanism: Activation of the sympathetic nervous system leading to increased heart rate and blood pressure.
Causes: Use of sympathomimetic agents like cocaine, amphetamines, or over-the-counter decongestants.
Time of Exposure: Can manifest within minutes to hours after intake.
Temperature: Can rise significantly, often exceeding 102°F.
Muscle Tone: Hypertonic with increased muscle tension.
Reflexes: Hyperreflexia.
Skin: Diaphoretic and flushed skin.
Urine: Increased output; may show metabolite presence.
Bowel Sounds: Increased activity noted; potential for excitement or agitation.
Diagnostic: Clinical presentation coupled with urinary drug screening.
Treatment: Administration of benzodiazepines for sedation, intravenous fluids, and close monitoring in a medical facility.
Anticholinergic Toxidrome:
Mechanism: Excessive blockade of acetylcholine leading to systemic anticholinergic effects.
Causes: Similar to anticholinergic toxicity from drugs, plants, or overdosage.
Time of Exposure: Symptoms may occur rapidly, often within minutes to hours.
Temperature: Hyperthermia typically exceeding 103°F.
Muscle Tone: Normal tone but muscle weakness can occur with severe cases.
Reflexes: Diminished or absent in severe cases.
Skin: Extremely dry, flushed, and possibly hot to the touch.
Urine: May become concentrated; possible retention due to altered bladder function.
Bowel Sounds: Reduced significantly due to decreased motility.
Skin Tones: Marked reddening and dryness throughout affected areas.
Diagnostic: Clinical examination and history are vital; urinary anticholinergic levels may help.
Treatment: Supportive care, monitoring, and possible use of physostigmine when necessary.
Types of Hyperthermic Toxidromes
Malignant Hyperthermia:
Mechanism: A genetic defect in the ryanodine receptor leads to uncontrolled calcium release from the sarcoplasmic reticulum of skeletal muscles during anesthesia.
Causes: Often triggered by certain anesthetic agents like halothane or succinylcholine in genetically predisposed individuals.
Time of Exposure: Symptoms can occur within minutes of exposure to anesthetic agents.
Temperature: Body temperature can rise to 106°F or higher.
Muscle Tone: Severe muscle rigidity occurs.
Reflexes: Hyperreflexia may be present.
Skin: Warm to hot skin, possibly mottled.
Urine: Dark, tea-colored urine due to myoglobinuria.
Bowel Sounds: Normal or decreased as a result of muscle rigidity and autonomic dysregulation.
Diagnostic: Increased creatine kinase levels and metabolic acidosis are indicative.
Treatment: Immediate administration of dantrolene, supportive care, and cooling measures are essential.
Serotonin Syndrome:
Mechanism: Excessive serotonergic activity in the central nervous system.
Causes: Often results from the interaction or overdose of serotonergic drugs (e.g., SSRIs, SNRIs, and certain recreational drugs).
Time of Exposure: Can develop rapidly, sometimes within hours of drug use or adjustment.
Temperature: Body temperature can exceed 104°F.
Muscle Tone: Increased muscle tone and rigidity may be noted.
Reflexes: Hyperreflexive with possible clonus.
Skin: Flushed, diaphoretic skin.
Urine: Mydriasis (dilated pupils) may yield normal urine output.
Bowel Sounds: Hyperactive.
Skin Tones: May appear reddened or mottled due to altered thermoregulation.
Diagnostic: Clinical diagnosis based on symptoms and medication history.
Treatment: Discontinuation of serotonergic agents, supportive care, and possible administration of cyproheptadine for severe cases.
Neuroleptic Malignant Syndrome:
Mechanism: Antipsychotic-induced dopamine receptor blockade causing severe muscle rigidity and metabolic dysregulation.
Causes: Associated with the use of antipsychotic medications, particularly first-generation (typical) antipsychotics.
Time of Exposure: Symptoms can develop within the first two weeks after initiation or dose increase.
Temperature: Can rise to 104°F or higher.
Muscle Tone: Extreme rigidity is prevalent.
Reflexes: Diminished or absent reflexes may occur.
Skin: Hot, dry skin due to autonomic dysregulation.
Urine: Rarely shows specific changes, but dehydration may lead to concentrated urine.
Bowel Sounds: Decreased bowel activity due to muscle rigidity.
Diagnostic: Elevated creatine kinase and leukocytosis; clinical assessment is key.
Treatment: Discontinue neuroleptics, provide supportive care, and administer dantrolene or bromocriptine to alleviate symptoms.
Anticholinergic Toxicity:
Mechanism: Blockade of acetylcholine receptors in the central and peripheral nervous systems.
Causes: Overdose of anticholinergic medications (e.g., atropine, scopolamine) or plants (e.g., belladonna).
Time of Exposure: Symptoms can emerge within one hour of exposure.
Temperature: Hyperthermia can exceed 103°F; difficulty regulating temperature.
Muscle Tone: Normal muscle tone with possible muscle weakness.
Reflexes: Diminished reflexes.
Skin: Dry, flushed skin; may present with rash.
Urine: Decreased urination; may become concentrated.
Bowel Sounds: Decreased bowel sounds due to reduced GI motility.
Skin Tones: Red and dry skin may be observable.
Diagnostic: Based on symptomatology and drug history; possible use of serum anticholinergic activity tests.
Treatment: Administration of physostigmine for severe cases, along with supportive care.
Stimulant-Induced Hyperthermia:
Mechanism: Increased catecholamine release causing elevated metabolic rates.
Causes: Excessive use of stimulants like cocaine, methamphetamine, or MDMA.
Time of Exposure: Symptoms usually present within minutes to hours of use.
Temperature: Body temperature can spike to 104°F or higher.
Muscle Tone: Increased muscle tone and potential hyperactivity.
Reflexes: Hyperreflexive.
Skin: Flushed and sweaty; possible pallor.
Urine: Mydriasis (dilated pupils) with possible changes in urine color due to dehydration.
Bowel Sounds: Hyperactive or normal.
Diagnostic: Clinical evaluation and toxicology screen; assess for other complications.
Treatment: Supportive care involving cooling measures, intravenous fluids, and monitoring vital signs closely.
Sympathomimetic Toxicity:
Mechanism: Activation of the sympathetic nervous system leading to increased heart rate and blood pressure.
Causes: Use of sympathomimetic agents like cocaine, amphetamines, or over-the-counter decongestants.
Time of Exposure: Can manifest within minutes to hours after intake.
Temperature: Can rise significantly, often exceeding 102°F.
Muscle Tone: Hypertonic with increased muscle tension.
Reflexes: Hyperreflexia.
Skin: Diaphoretic and flushed skin.
Urine: Increased output; may show metabolite presence.
Bowel Sounds: Increased activity noted; potential for excitement or agitation.
Diagnostic: Clinical presentation coupled with urinary drug screening.
Treatment: Administration of benzodiazepines for sedation, intravenous fluids, and close monitoring in a medical facility.
Anticholinergic Toxidrome:
Mechanism: Excessive blockade of acetylcholine leading to systemic anticholinergic effects.
Causes: Similar to anticholinergic toxicity from drugs, plants, or overdosage.
Time of Exposure: Symptoms may occur rapidly, often within minutes to hours.
Temperature: Hyperthermia typically exceeding 103°F.
Muscle Tone: Normal tone but muscle weakness can occur with severe cases.
Reflexes: Diminished or absent in severe cases.
Skin: Extremely dry, flushed, and possibly hot to the touch.
Urine: May become concentrated; possible retention due to altered bladder function.
Bowel Sounds: Reduced significantly due to decreased motility.
Skin Tones: Marked reddening and dryness throughout affected areas.
Diagnostic: Clinical examination and history are vital; urinary anticholinergic levels may help.
Treatment: Supportive care, monitoring, and possible use of physostigmine when necessary.